Global Influenza Medication Market Insights, Forecast to 2025

Publisher Name :
Date: 10-Sep-2018
No. of pages: 115
Inquire Before Buying

This report studies the global market size of Influenza Medication in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Influenza Medication in these regions.

This research report categorizes the global Influenza Medication market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.

In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.

In 2017, the global Influenza Medication market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Influenza Medication market based on company, product type, application and key regions.

The various contributors involved in the value chain of Influenza Medication include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Influenza Medication include

- Daiichi Sankyo Company

- GlaxoSmithKline

- Natco Pharma

- F. Hoffmann-La Roche

- Teva Pharmaceutical

- Sandoz International GmbH (Novartis AG)

- Sun Pharmaceutical Industries

- Mylan

Market Size Split by Type

- Zanamivir

- Oseltamivir

- Peramivir

- Amantadine

- Rimantadine

- Inosine

- Other

Market Size Split by Application

- Hospitals

- Clinics

- Pharmacies

- Others

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Influenza Medication market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Influenza Medication market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Influenza Medication manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Influenza Medication with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Influenza Medication submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Influenza Medication are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Influenza Medication market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Influenza Medication Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Influenza Medication Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Influenza Medication Market Size Growth Rate by Type
1.4.2 Zanamivir
1.4.3 Oseltamivir
1.4.4 Peramivir
1.4.5 Amantadine
1.4.6 Rimantadine
1.4.7 Inosine
1.4.8 Other
1.5 Market by Application
1.5.1 Global Influenza Medication Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Medication Market Size
2.1.1 Global Influenza Medication Revenue 2016-2025
2.1.2 Global Influenza Medication Sales 2016-2025
2.2 Influenza Medication Growth Rate by Regions
2.2.1 Global Influenza Medication Sales by Regions
2.2.2 Global Influenza Medication Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Influenza Medication Sales by Manufacturers
3.1.1 Influenza Medication Sales by Manufacturers
3.1.2 Influenza Medication Sales Market Share by Manufacturers
3.1.3 Global Influenza Medication Market Concentration Ratio (CR5 and HHI)
3.2 Influenza Medication Revenue by Manufacturers
3.2.1 Influenza Medication Revenue by Manufacturers (2016-2018)
3.2.2 Influenza Medication Revenue Share by Manufacturers (2016-2018)
3.3 Influenza Medication Price by Manufacturers
3.4 Influenza Medication Manufacturing Base Distribution, Product Types
3.4.1 Influenza Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Medication Product Category
3.4.3 Date of International Manufacturers Enter into Influenza Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Influenza Medication Sales by Type
4.2 Global Influenza Medication Revenue by Type
4.3 Influenza Medication Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Influenza Medication Breakdown Data by Application
6 North America
6.1 North America Influenza Medication by Countries
6.1.1 North America Influenza Medication Sales by Countries
6.1.2 North America Influenza Medication Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Influenza Medication by Type
6.3 North America Influenza Medication by Application
6.4 North America Influenza Medication by Company
7 Europe
7.1 Europe Influenza Medication by Countries
7.1.1 Europe Influenza Medication Sales by Countries
7.1.2 Europe Influenza Medication Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Medication by Type
7.3 Europe Influenza Medication by Application
7.4 Europe Influenza Medication by Company
8 Asia Pacific
8.1 Asia Pacific Influenza Medication by Countries
8.1.1 Asia Pacific Influenza Medication Sales by Countries
8.1.2 Asia Pacific Influenza Medication Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Influenza Medication by Type
8.3 Asia Pacific Influenza Medication by Application
8.4 Asia Pacific Influenza Medication by Company
9 Central & South America
9.1 Central & South America Influenza Medication by Countries
9.1.1 Central & South America Influenza Medication Sales by Countries
9.1.2 Central & South America Influenza Medication Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Influenza Medication by Type
9.3 Central & South America Influenza Medication by Application
9.4 Central & South America Influenza Medication by Company
10 Middle East and Africa
10.1 Middle East and Africa Influenza Medication by Countries
10.1.1 Middle East and Africa Influenza Medication Sales by Countries
10.1.2 Middle East and Africa Influenza Medication Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Influenza Medication by Type
10.3 Middle East and Africa Influenza Medication by Application
10.4 Middle East and Africa Influenza Medication by Company
11 Company Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Influenza Medication
11.1.4 Influenza Medication Product Description
11.1.5 Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Influenza Medication
11.2.4 Influenza Medication Product Description
11.2.5 Recent Development
11.3 Natco Pharma
11.3.1 Natco Pharma Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Influenza Medication
11.3.4 Influenza Medication Product Description
11.3.5 Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Influenza Medication
11.4.4 Influenza Medication Product Description
11.4.5 Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Influenza Medication
11.5.4 Influenza Medication Product Description
11.5.5 Recent Development
11.6 Sandoz International GmbH (Novartis AG)
11.6.1 Sandoz International GmbH (Novartis AG) Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Influenza Medication
11.6.4 Influenza Medication Product Description
11.6.5 Recent Development
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Influenza Medication
11.7.4 Influenza Medication Product Description
11.7.5 Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Influenza Medication
11.8.4 Influenza Medication Product Description
11.8.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Influenza Medication Raw Material
13.1.2 Influenza Medication Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Influenza Medication
Figure Global Influenza Medication Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Influenza Medication Production Market Share by Types (Product Category) in 2017
Figure Zanamivir Product Picture
Table Major Manufacturers of Zanamivir
Figure Oseltamivir Product Picture
Table Major Manufacturers of Oseltamivir
Figure Peramivir Product Picture
Table Major Manufacturers of Peramivir
Figure Amantadine Product Picture
Table Major Manufacturers of Amantadine
Figure Rimantadine Product Picture
Table Major Manufacturers of Rimantadine
Figure Inosine Product Picture
Table Major Manufacturers of Inosine
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Influenza Medication Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Pharmacies
Figure Others
Figure Influenza Medication Report Years Considered
Figure Global Influenza Medication Market Size 2016-2025 (Million US$)
Figure Global Influenza Medication Sales 2016-2025 (K Units)
Table Global Influenza Medication Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Influenza Medication Sales by Regions 2016-2025 (K Units)
Table Global Influenza Medication Sales Market Share by Regions 2016-2025
Figure Global Influenza Medication Sales Market Share by Regions 2016-2025
Figure 2017 Global Influenza Medication Sales Market Share by Regions
Table Global Influenza Medication Revenue by Regions 2016-2025 (Million US$)
Table Global Influenza Medication Revenue Market Share by Regions 2016-2025
Figure Global Influenza Medication Revenue Market Share by Regions 2016-2025
Figure 2017 Global Influenza Medication Revenue Market Share by Regions
Table Global Influenza Medication Sales by Manufacturers (2016-2018) (K Units)
Table Global Influenza Medication Sales Share by Manufacturers (2016-2018)
Figure Global Influenza Medication Sales Share by Manufacturers in 2017
Table Influenza Medication Revenue by Manufacturers (2016-2018) (Million US$)
Table Influenza Medication Revenue Share by Manufacturers (2016-2018)
Figure Influenza Medication Value Share by Manufacturers in 2017
Table Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Influenza Medication Price (2016-2018) (USD/Unit)
Table Influenza Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Influenza Medication Product Category
Table Date of International Manufacturers Enter into Influenza Medication Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Influenza Medication Sales by Type (2016-2025) (K Units)
Table Global Influenza Medication Sales Share by Type (2016-2025)
Figure Global Influenza Medication Sales Market Share by Type (2016-2025)
Figure Global Influenza Medication Sales Market Share by Type in 2017
Table Global Influenza Medication Revenue by Type (2016-2025) (Million US$)
Table Global Influenza Medication Revenue Share by Type (2016-2025)
Figure Global Influenza Medication Revenue Market Share by Type (2016-2025)
Figure Global Influenza Medication Revenue Market Share by Type in 2017
Table Influenza Medication Price by Type 2013-2018 (USD/Unit)
Table Global Influenza Medication Sales by Application (2016-2025) (K Units)
Table Global Influenza Medication Sales Share by Application (2016-2025)
Figure Global Sales Influenza Medication Market Share by Application (2016-2025)
Figure Global Sales Influenza Medication Market Share by Application (2016-2025)
Figure North America Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure North America Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table North America Influenza Medication Sales by Countries (2016-2025) (K Units)
Table North America Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 North America Influenza Medication Sales Market Share by Countries
Table North America Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table North America Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Influenza Medication Revenue Market Share by Countries
Figure United States Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure United States Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Canada Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table North America Influenza Medication Sales by Type (2016-2025) (K Units)
Table North America Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 North America Influenza Medication Market Share by Type
Table North America Influenza Medication Sales by Application (2016-2025) (K Units)
Table North America Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 North America Influenza Medication Market Share by Application
Table North America Influenza Medication Sales by Company (2016-2018) (K Units)
Table North America Influenza Medication Sales Market Share by Company (2016-2018)
Figure North America Influenza Medication Sales Market Share by Company in 2017
Figure Europe Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Europe Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Europe Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Influenza Medication Sales Market Share by Countries
Table Europe Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Europe Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Influenza Medication Revenue Market Share by Countries
Figure Germany Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Germany Influenza Medication Revenue Growth Rate (2016-2025) (K Units)
Figure France Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure France Influenza Medication Revenue Growth Rate (2016-2025) (K Units)
Figure UK Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure UK Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Italy Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Russia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Influenza Medication Sales by Type (2016-2025) (K Units)
Table Europe Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Europe Influenza Medication Market Share by Type
Table Europe Influenza Medication Sales by Application (2016-2025) (K Units)
Table Europe Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Europe Influenza Medication Market Share by Application
Table Europe Influenza Medication Sales by Company (2016-2018) (K Units)
Table Europe Influenza Medication Sales Market Share by Company (2016-2018)
Figure Europe Influenza Medication Sales Market Share by Company in 2017
Figure Asia Pacific Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Sales Market Share by Countries
Table Asia Pacific Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Revenue Market Share by Countries
Figure China Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure China Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Japan Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Korea Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure India Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure India Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Australia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Influenza Medication Sales by Type (2016-2025) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Market Share by Type
Table Asia Pacific Influenza Medication Sales by Application (2016-2025) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Market Share by Application
Table Asia Pacific Influenza Medication Sales by Company (2016-2018) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Company (2016-2018)
Figure Asia Pacific Influenza Medication Sales Market Share by Company in 2017
Figure Central & South America Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Influenza Medication Sales Market Share by Countries
Table Central & South America Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Influenza Medication Revenue Market Share by Countries
Figure Brazil Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Influenza Medication Sales by Type (2016-2025) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Influenza Medication Market Share by Type
Table Central & South America Influenza Medication Sales by Application (2016-2025) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Influenza Medication Market Share by Application
Table Central & South America Influenza Medication Sales by Company (2016-2018) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Company (2016-2018)
Figure Central & South America Influenza Medication Sales Market Share by Company in 2017
Figure Middle East and Africa Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Sales Market Share by Countries
Table Middle East and Africa Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Revenue Market Share by Countries
Figure GCC Countries Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Influenza Medication Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Market Share by Type
Table Middle East and Africa Influenza Medication Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Market Share by Application
Table Middle East and Africa Influenza Medication Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Influenza Medication Sales Market Share by Company in 2017
Table Daiichi Sankyo Company Company Details
Table Daiichi Sankyo Company Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Daiichi Sankyo Company Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Natco Pharma Company Details
Table Natco Pharma Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Natco Pharma Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Pharmaceutical Recent Development
Table Sandoz International GmbH (Novartis AG) Company Details
Table Sandoz International GmbH (Novartis AG) Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sandoz International GmbH (Novartis AG) Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sun Pharmaceutical Industries Recent Development
Table Mylan Company Details
Table Mylan Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mylan Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Influenza Medication Value Chain
Table Typical Suppliers of Key Influenza Medication Raw Material
Table Influenza Medication Customers List
Table Influenza Medication Sales Channels
Table Influenza Medication Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Sexual Wellness Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Sexual wellness refers to the physical, mental, and sexual well-being of people. Products such as erotic lingerie, condoms and contraceptives, personal lubricants, sex toys, and others such as testing cards and pregnancy testing kits, sexual enhancement supplements, sex games, and vaginal sexual wellness products, which enhance safety and pleasure of sexual experiences, are considered sexual wellness products. Scope of the Report: This report focuses on the Sexual Wellness ......
  • Global Oseltamivir Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 102
    Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B (flu). Scope of the Report: This report focuses on the Oseltamivir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Oseltamivir is expected to grow at a CAGR of roug......
  • Global Over The Counter (OTC) Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 119
    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Scope of the Report: This report focuses on the Over The Counter (OTC) Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, re......
  • Global Over the Counter (OTC) Drugs & Dietary Supplements Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements. Scope of the Report:......
  • Global Asthma Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. Scope of the Report: This report focuses on the Asthma Drugs in global market, especially in......
  • Global Atopic Dermatitis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized). Scope of the Report: This report focuses on the Atopic Dermatitis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. One of the major factors responsible for the growing risk ......
  • Global Latex Allergy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Latex allergy is caused by exposure to substances made of latex (natural rubber). The exposure leads to a person's immune system reaction to harmless protein in such a way as if the proteins are antigens, or disease causing. Antibodies and antihistamines get released in the body as result so as to react to the natural harmless proteins which may cause symptoms such as itchy hands, skin rash, hives, and eczema (cracking of skin). It is commonly caused in people who are exposed to latex based prod......
  • Global Labyrinthitis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 118
    Labyrinthitis, also known as vestibular neuritis, is an inflammation of the inner earor the nerves that connect the inner ear to the brain due to a variety of reasons such as infection by measles, mumps, trauma, autoimmune etc. Scope of the Report: This report focuses on the Labyrinthitis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ......
  • Global Home Infusion Therapy Services Market Size, Status and Forecast 2018-2025
    Published: 21-Sep-2018        Price: US 3900 Onwards        Pages: 99
    Home infusion therapy services offer an innovative healthcare services at the doorsteps. Infusion therapy administer medication through needle or a catheter. Infusion therapy is generally used when the patient's condition is very severe and cannot be cured with the oral medication. Home infusion is best described as most convenient for patient particularly when the infusion is needed multiple times in a day or long term care. Disease which need infusion therapies include cancer and cancer relate......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs